Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Celyad Oncology Appoints Georges Rawadi as Its New CEO
Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]
Morphimmune Appoints Dr. Clay Siegall Chief Executive Officer and President
Morphimmune, a preclinical biotechnology company focused on developing targeted oncology therapeutics, today announced the appointment […]
Capstan Therapeutics Appoints Justin Thacker as Chief Financial Officer and Jeffrey Pepe, J.D., Ph.D., as General Counsel
Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through targeted […]
Ankyra Therapeutics Appoints Experienced Financial Executive Stephen Gorgol as Chief Financial Officer
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, has […]
Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO
Semler Scientific, a company that provides technology solutions to improve the clinical effectiveness and efficiency […]
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors
NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that […]
Gamida Cell Announces Changes to Board of Directors
Gamida Cell, a cell therapy pioneer working to turn cells into powerful therapeutics, today announced […]
Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer
Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]
Nanoscope Therapeutics Appoints Industry Veteran Vicente Anido Jr., Ph.D., as a Strategic Advisor
Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more